
    
      The study involves tree MRI sessions, two FDG-PET-CT sessions and one FMISO-PET session. The
      FMISO-PET session is presently not carried out because of delivery problems. The production
      of 18F-fluoromisonidazol at The Department of Clinical Physiology and Nuclear Medicine,
      Copenhagen University Hospital Herlev, Denmark has not jet been approved by the Danish
      Medicines Agency.
    
  